BR

BellRing Brands, Inc.

BRBRConsumer DefensiveNASDAQ

Packaged Foods · Last scanned Sep 4, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150-24.03%
$13.69

Price below medium-term moving average.

MA200-39.88%
$17.30

Below long-term trend line.

RSI-14neutral
46.3

Balanced. Not overbought, not oversold.

MACDpositive
+0.0212

Histogram positive, upward momentum.

Financials · Annual
Revenue
$2.32B
+16.1% YoY
Net Income
$216.2M
-12.3% YoY
EBITDA
$376.0M
-11.4% YoY
Free Cash Flow
$201.1M

Scan Results

Daily timeframe

1 of 4 indicators bullish as of Sep 3

1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Positive CrossoverHistogram +0.0232, positive momentum
Sep 2 MACD Negative CrossoverHistogram -0.0023, negative momentum
About BellRing Brands, Inc.

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States. Valued at $1.21B, BRBR is a small-cap name in its sector. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, protein powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands.

Where BRBR stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, BRBR finished 22.26% below its 150-day moving average ($13.79) and 38.32% below its 200-day moving average ($17.38). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is BRBR overbought or oversold?

At the September 3, 2026 close, BRBR's RSI(14) was 47.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.21B
P/E (TTM)7.54
Fwd P/E7.87
EPS$1.38
Beta0.52
52W Change-72.8%
Analysis

On the balance sheet, BRBR has $50.4M in cash with $1.17B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $201.1M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on assets of 19.1% further supports the picture of efficient asset utilization. Revenue has grown from $1.37B (2022) to $2.32B (2025), reflecting a 69% increase over the period.

BRBR's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing BRBR.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms